328
Views
43
CrossRef citations to date
0
Altmetric
Research Article

Metabolic Engineering of Plant L-Ascorbic Acid Biosynthesis: Recent Trends and Applications

, , , , &
Pages 173-182 | Published online: 10 Oct 2008
 

ABSTRACT

Vitamin C (L-ascorbic acid; AsA) is the major soluble antioxidant found in plants and is also an essential component of human nutrition. Although numerous biotechnological methods have been exploited to increase its yield, pressures such as commercial competition and environmental concerns make it urgent to find a new way for industrial production of plant-derived AsA. Engineering plant AsA has now become feasible because of our increased understanding of its biosynthetic pathway. Several possible strategies could be followed to increase AsA production, such as overcoming the rate limiting steps in the biosynthetic pathway, promoting recycling, and reducing catabolism. For these purposes, genes of plant, microbial and animal origins have been successfully used. Several examples will be given to illustrate these various approaches. The existing and potential achievements in increasing AsA production would provide the opportunity for enhancing nutritional quality and stress tolerance of crop plants.

Abbreviation:
2-CP,=

2-cysteine peroxiredoxin;

ADLT,=

aldono-lactonase (EC 3.1.1.17);

ALO,=

arabinono-1, 4-lactone oxidase;

AO,=

Ascorbateoxidase (EC 1.10.3.3);

APX,=

Ascorbate peroxidaseEC1.11.1.11);

AsA,=

L-ascorbic acid;

DHA,=

dehydroascorbate;

DHAR,=

dehydroascorbate reductase (EC 1.8.5.1);

GalUR,=

D-galacturonate reductase (EC 1.1.1.19);

GDPME,=

GDP-D-mannose-3, epimerase (EC 5.1.3.18);

GDPMPPase,=

GDP-D-mannose pyrophosphorylase EC 2.7.7.22);

GR,=

glutathione reductase;

GSH,=

glutathione;

GSSG,=

Oxidized glutathione;

HK,=

hexokinase (EC 2.7.1.1);

L-GalDH,=

L-galactose dehydrogenase;

L-GalPPase,=

L-galactose 1-P phosphatase;

L-GLDH,=

L-galactono-1, 4-lactone dehydrogenase (EC 1.3.2.3);

MDHA,=

monodehydroascorbate;

MDHAR,=

monodehydroascorbate reductase (EC 1.6.5.4);

ME,=

methylesterase;

MI,=

myo-inositol;

MIOX,=

homozygous myo-inositol oxygenase;

PGI,=

phosphoglucose isomerase (EC 5.3.1.9);

PMI,=

phosphomannose isomerase (EC 5.3.1.8);

PMM,=

phosphomannose mutase (EC 5.4.2.8);

RNAi,=

RNA interfering;

VHb,=

Vitreoscilla hemoglobin.

Abbreviation:
2-CP,=

2-cysteine peroxiredoxin;

ADLT,=

aldono-lactonase (EC 3.1.1.17);

ALO,=

arabinono-1, 4-lactone oxidase;

AO,=

Ascorbateoxidase (EC 1.10.3.3);

APX,=

Ascorbate peroxidaseEC1.11.1.11);

AsA,=

L-ascorbic acid;

DHA,=

dehydroascorbate;

DHAR,=

dehydroascorbate reductase (EC 1.8.5.1);

GalUR,=

D-galacturonate reductase (EC 1.1.1.19);

GDPME,=

GDP-D-mannose-3, epimerase (EC 5.1.3.18);

GDPMPPase,=

GDP-D-mannose pyrophosphorylase EC 2.7.7.22);

GR,=

glutathione reductase;

GSH,=

glutathione;

GSSG,=

Oxidized glutathione;

HK,=

hexokinase (EC 2.7.1.1);

L-GalDH,=

L-galactose dehydrogenase;

L-GalPPase,=

L-galactose 1-P phosphatase;

L-GLDH,=

L-galactono-1, 4-lactone dehydrogenase (EC 1.3.2.3);

MDHA,=

monodehydroascorbate;

MDHAR,=

monodehydroascorbate reductase (EC 1.6.5.4);

ME,=

methylesterase;

MI,=

myo-inositol;

MIOX,=

homozygous myo-inositol oxygenase;

PGI,=

phosphoglucose isomerase (EC 5.3.1.9);

PMI,=

phosphomannose isomerase (EC 5.3.1.8);

PMM,=

phosphomannose mutase (EC 5.4.2.8);

RNAi,=

RNA interfering;

VHb,=

Vitreoscilla hemoglobin.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.